Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST

NCT03858478 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
110
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba